FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2951446689> ?p ?o ?g. }

• W2951446689 abstract "Background Checkpoint inhibitor therapy has caused a paradigm shift in the field of oncology, producing significant survival benefits in patients with an ever-growing list of malignancies, but their use is attended by a spectrum of immune related adverse events (irAEs). Many rheumatic irAEs have been described. A critical and presently unanswered question is what proportion of these rheumatic irAEs represent new appearances of classic rheumatic diseases or, alternatively, represent new clinical variants with potentially different pathogenesis, clinical course and treatment responsiveness. Little is known about the PMR-like entity that has been described in the setting of ICI therapy. Objectives To assess whether the polymyalgia rheumatica (PMR)-like syndrome reported as an irAE from checkpoint inhibitor therapy is consistent with the 2012 EULAR/ACR provisional criteria for PMR1. Methods The cases were derived from two sources. Group 1 represents reported cases from three contributing centers. Group 2 was derived from a systematic review of the literature searching for all cases reported as PMR or PMR-like illness associated with checkpoint inhibitor therapy. Cases were assessed for the quality of reporting and then analyzed to determine whether they fulfilled the 2012 EULAR/ACR provisional criteria for PMR. Results A total of 49 patients were included for analysis, including 9 cases from Cleveland Clinic (Table 1), 4 cases from Johns Hopkins University, and 7 cases from University Hospital of Bordeaux, in addition to the 29 separate cases found by systematic review. Among the entire group, 37 (75%) were designated “complete” indicating that they had sufficient data to reliably apply the 2012 EULAR/ACR criteria of which 28 (75%) cases fulfilled complete criteria for PMR. A number of cases also demonstrated some clinical features unusual for idiopathic PMR. Conclusion This study suggests a high proportion of reported cases of checkpoint inhibitor-related PMR fulfill preliminary criteria for PMR yet in one quarter clinical details were incomplete making verification problematic. Furthermore, in the absence of a gold standard for the diagnosis of PMR, the relationship of checkpoint inhibitor-related PMR to the idiopathic form remains unclear. References [1] Dasgupta B, Cimmino MA, Maradit-Kremers H, et al. 2012provisional classification criteria for polymyalgia rheumatic: a European League Against Rheumatism/American College of Rheumatology collaborative initiative. Ann Rheum Dis2012;71:484-492. Disclosure of Interests cassandra calabrese Speakers bureau: Regeneron/Sanofi, Laura Cappelli Grant/research support from: Bristol-Myers Squibb, Consultant for: Regeneron/Sanofi Genzyme, Marie Kostine: None declared, Elizabeth Kirchner Consultant for: Celgene, Horizon, Novartis, Regeneron, Speakers bureau: Merck and Sanofi, Tawnie Braaten Grant/research support from: supported by T32 grant and “research reported in this publication was supported by the National Institute of Arthritis and Musculoskeletal and Skin Diseases of the National Institutes of Health under Award Number T32AR048522. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.”, Leonard Calabrese Consultant for: Bristol-Myers-Squibb, Genentech and Astra-Zeneca." @default.
• W2951446689 created "2019-06-27" @default.
• W2951446689 creator A5004159138 @default.
• W2951446689 creator A5004856138 @default.
• W2951446689 creator A5006332537 @default.
• W2951446689 creator A5031868807 @default.
• W2951446689 creator A5033533727 @default.
• W2951446689 creator A5036748733 @default.
• W2951446689 date "2019-06-01" @default.
• W2951446689 modified "2023-09-25" @default.
• W2951446689 title "THU0567 POLYMYALGIA RHEUMATICA-LIKE SYNDROME FROM CHECKPOINT INHIBITOR THERAPY: CASE SERIES AND SYSTEMATIC REVIEW OF THE LITERATURE" @default.
• W2951446689 doi "https://doi.org/10.1136/annrheumdis-2019-eular.1389" @default.
• W2951446689 hasPublicationYear "2019" @default.
• W2951446689 type Work @default.
• W2951446689 sameAs 2951446689 @default.
• W2951446689 citedByCount "0" @default.
• W2951446689 crossrefType "proceedings-article" @default.
• W2951446689 hasAuthorship W2951446689A5004159138 @default.
• W2951446689 hasAuthorship W2951446689A5004856138 @default.
• W2951446689 hasAuthorship W2951446689A5006332537 @default.
• W2951446689 hasAuthorship W2951446689A5031868807 @default.
• W2951446689 hasAuthorship W2951446689A5033533727 @default.
• W2951446689 hasAuthorship W2951446689A5036748733 @default.
• W2951446689 hasBestOaLocation W29514466891 @default.
• W2951446689 hasConcept C121608353 @default.
• W2951446689 hasConcept C126322002 @default.
• W2951446689 hasConcept C143998085 @default.
• W2951446689 hasConcept C197934379 @default.
• W2951446689 hasConcept C2776015282 @default.
• W2951446689 hasConcept C2776712624 @default.
• W2951446689 hasConcept C2777701055 @default.
• W2951446689 hasConcept C2779134260 @default.
• W2951446689 hasConcept C2780057760 @default.
• W2951446689 hasConcept C2780079024 @default.
• W2951446689 hasConcept C71924100 @default.
• W2951446689 hasConceptScore W2951446689C121608353 @default.
• W2951446689 hasConceptScore W2951446689C126322002 @default.
• W2951446689 hasConceptScore W2951446689C143998085 @default.
• W2951446689 hasConceptScore W2951446689C197934379 @default.
• W2951446689 hasConceptScore W2951446689C2776015282 @default.
• W2951446689 hasConceptScore W2951446689C2776712624 @default.
• W2951446689 hasConceptScore W2951446689C2777701055 @default.
• W2951446689 hasConceptScore W2951446689C2779134260 @default.
• W2951446689 hasConceptScore W2951446689C2780057760 @default.
• W2951446689 hasConceptScore W2951446689C2780079024 @default.
• W2951446689 hasConceptScore W2951446689C71924100 @default.
• W2951446689 hasLocation W29514466891 @default.
• W2951446689 hasOpenAccess W2951446689 @default.
• W2951446689 hasPrimaryLocation W29514466891 @default.
• W2951446689 hasRelatedWork W1993277391 @default.
• W2951446689 hasRelatedWork W2177213102 @default.
• W2951446689 hasRelatedWork W2315535010 @default.
• W2951446689 hasRelatedWork W2339504826 @default.
• W2951446689 hasRelatedWork W2416801198 @default.
• W2951446689 hasRelatedWork W2556474060 @default.
• W2951446689 hasRelatedWork W2753999978 @default.
• W2951446689 hasRelatedWork W2952466219 @default.
• W2951446689 hasRelatedWork W2953033724 @default.
• W2951446689 hasRelatedWork W3038417198 @default.
• W2951446689 hasRelatedWork W3041968643 @default.
• W2951446689 hasRelatedWork W3046299870 @default.
• W2951446689 hasRelatedWork W3048783965 @default.
• W2951446689 hasRelatedWork W3099993137 @default.
• W2951446689 hasRelatedWork W3115768774 @default.
• W2951446689 hasRelatedWork W3164025901 @default.
• W2951446689 hasRelatedWork W3164255007 @default.
• W2951446689 hasRelatedWork W3165878353 @default.
• W2951446689 hasRelatedWork W3212832225 @default.
• W2951446689 isParatext "false" @default.
• W2951446689 isRetracted "false" @default.
• W2951446689 magId "2951446689" @default.
• W2951446689 workType "article" @default.